The announcement of a structured plan to resolve significant legal challenges related to ovarian cancer talc claims is seen as a positive development for Johnson & Johnson. It suggests a proactive approach to managing and potentially limiting future legal liabilities, which can be a significant concern for investors. This move is likely to be viewed favorably by the market as it may reduce the uncertainty surrounding the company's financial and legal outlook, thus the positive impact on the stock price in the short term.